Erwan Atcheson1
Philip J. Skuce
Nicola A. M. Oliver
Tom N. McNeilly
Mark W. Robinson- 1Microbes and Pathogen Biology, School of Biological Sciences, Queen's University Belfast, Belfast, United Kingdom
- 2Disease Control, Moredun Research Institute, Pentlands Science Park, Edinburgh, United Kingdom
Paramphistomosis—An Established Infection in European Livestock
Infections by parasitic flukes are an important animal health and production concern for livestock producers worldwide. In the UK, and throughout the EU, liver fluke (Fasciola hepatica) historically has been a major focus for livestock farmers. However, in recent years, there has been a sharp increase in the incidence of rumen fluke (or paramphistome) infections in both sheep and cattle, such that they are now more common than liver fluke in many areas (1). The predominant rumen fluke species in the UK and Ireland has been confirmed as Calicophoron daubneyi (2), which appears to have spread from mainland Europe where it is common in countries such as France, Spain, and Belgium (1). Although there have been limited reports of Paramphistomum leydeni in Ireland (3, 4) and the Netherlands (5) the importance/pathogenicity of this species has not been investigated. Although the exact reasons for the increase in rumen fluke infections are not fully understood, the increase in warm wet summers and mild winters—conditions that favor Galba truncatula, the confirmed snail intermediate host of both F. hepatica and C. daubneyi—are thought to be the major contributing factor (6). It has also been suggested that C. daubneyi is adapting to out-compete the already endemic F. hepatica in their shared environment and snail intermediate host species (7). Furthermore, the widespread use of fasciolicides, to target liver fluke—most but not all are specific for liver fluke—may be giving C. daubneyi further competitive advantage over F. hepatica, such that C. daubneyi may eventually replace F. hepatica as the most prevalent endemic trematode in the UK/Ireland (8).
C. daubneyi—A Growing Threat to UK Agriculture?
Acute, clinical paramphistomosis is caused when grazing livestock (typically youngstock in cattle or sheep of any age) ingest large numbers of rumen fluke metacercariae (cysts) from pasture, which then excyst en masse in the duodenum (Figure 1A). The newly excysted juvenile (NEJ) flukes then migrate into the intestinal submucosa causing significant damage to the host tissue (9). Large areas of damaged small intestine may hemorrhage, causing significant blood loss, and hypoalbuminaemia (10, 11). This initial damage, together with secondary bacterial infection, may trigger significant haemorrhagic enteritis, which often presents with fetid, black or bloody diarrhea (10, 12), and can result in mortality at this point. After feeding on the host tissue in the proximal small intestine (duodenum), immature paramphistomes migrate to the rumen where they mature (Figure 1B), with infections becoming patent at around 8–10 weeks post-infection (13). Although clinical disease is not currently associated with chronic paramphistome infections (which are common in the UK/Ireland, especially in cattle), post-mortem observations have noted both rumenitis and abomasitis in infected animals (14, 15), along with atrophy of the rumen papillae (1, 15). These effects may explain the (anecdotal) evidence from farmers that infected animals do not thrive, but respond well to oxyclozanide, the recommended treatment for rumen fluke.
Figure 1. H&E-stained sections of (A) immature C. daubneyi larvae in situ within the duodenal mucosa and (B) an adult fluke attached to a rumen papilla via its muscular posterior acetabulum.
Whilst paramphistomes are common in the UK/Ireland, clinical disease (i.e., poor condition/emaciation, with or without death, associated with acute infection) as described by Millar et al. (12) and Mason et al. (15) is still relatively rare. However, fatal disease outbreaks, linked to significant immature parasite burdens, are on the rise in both sheep and cattle (8, 11, 12, 15). For example, in a particularly severe outbreak on an Irish farm, 6-months old dairy heifers ingested an estimated 5,334 metacercariae each day over 3 weeks (8). Indeed, the Disease Surveillance and Investigation Branch of the Agri-food and Biosciences Institute (Northern Ireland) are seeing an increasing number of sudden deaths that showed no clinical presentation other than acute rumen fluke infection at post-mortem examination—particularly during years with mild wet conditions during the spring and early summer (Prof. Bob Hanna, personal communication, 2019). With the increasing prevalence of rumen fluke in the UK/Ireland, outbreaks of clinical (and fatal) paramphistomosis may rise further in the future.
With Limited Treatment Options, Sustainable Control of Rumen Fluke Infection Looks Challenging
Given the rapid clinical progression associated with acute paramphistomosis, swift diagnosis, and timely interventions will be key in the treatment of disease outbreaks. However, neither of these is straightforward. ELISA-based diagnostic tests have yet to be developed for rumen fluke infections, [the current F. hepatica coproantigen test does not cross-react with C. daubneyi; Kajugu et al. (16)] leaving fecal egg counts or post mortem as the only options to identify chronic or acute disease, respectively (1). In addition, whilst some compounds show efficacy against the infection, there are currently no licensed anthelmintics available to control rumen fluke in the UK or Ireland. Closantel showed high activity in cattle when given as an oral drench (17) but had limited/no effect when injected subcutaneously (18, 19). In contrast, oxyclozanide has consistently shown high efficacy against juvenile and adult rumen fluke in cattle and goats (18, 20). However, reliance on a single drug for treatment of this potentially fatal parasite infection is not sustainable, and particularly worrying, since the emergence of drug-resistant rumen fluke populations following oxyclozanide mono-therapy would be inevitable. This situation will leave animal producers with little to combat the disease (agronomic approaches to control rumen fluke would likely be as effective as those for liver fluke since they use the same snail intermediate host). Consequently, a vaccine that would prevent rumen fluke infection and/or limit damaging intestinal pathology would be beneficial.
Rumen Fluke May Be More Amenable To Control by Vaccination Than Liver Fluke
Field observations indicate that previous exposure of livestock to rumen fluke provides protection against massive infections that would typically cause acute paramphistomosis (9). For example, during a fatal outbreak of paramphistomosis caused by Paramphistomum ichikawai in lambs, adult ewes exposed to the same infected pasture harbored adult rumen flukes but had few immature intestinal stage parasites and were unaffected by the disease (21). These findings are supported by experimental studies in which sheep, cattle, and goats were successfully immunized with Paramphistomum microbothrium metacercariae, routinely reaching >99% protection against challenge infection (22, 23). Interestingly, these studies showed that immunization with adult worms (delivered orally to establish infection directly in the rumen) was not effective and that protective immunity requires exposure of the duodenum to NEJ-derived antigen. In contrast, host rumen fluke burdens have been shown to grow with age (24) indicating that protective immunity may not be widespread under field conditions. Nevertheless, there is more evidence for immunity to re-infection compared to liver fluke where natural acquired immunity is limited in cattle and less so in sheep (25). As a result, attempts to vaccinate livestock against liver fluke have been largely unsuccessful, despite considerable research effort (26).
Research Priorities for a Better Understanding of Rumen Fluke Pathogenicity
Despite their prevalence, our knowledge of many aspects of basic rumen fluke biology, and how they interact with their hosts, is limited. This is in contrast to F. hepatica, the other major endemic trematode species in the UK, for which we have a very good understanding of the key metabolic, biochemical and molecular mechanisms underpinning invasion, virulence, and development, as well as a clear picture of the immune responses (in rodent and ruminant hosts) which define the cellular and molecular signatures of liver fluke infection (27–31).
Here, we list some research priorities, for C. daubneyi, based on the need to better understand the pathogenicity of this species and how the ruminant host responds to infection.
Sources of Viable C. daubneyi Metacercariae
Currently, the only source of C. daubneyi metacercariae in the UK is Ridgeway Research Ltd. (St. Briavels, UK). Whilst it is possible to obtain large numbers of metacercariae by washing them directly from significantly contaminated pasture (8), access is seasonal and there is always a danger that these washings will contain cysts of F. hepatica or other trematode species. Clearly, establishment of other sources of experimentally-produced rumen fluke metacercariae would be beneficial to the research community.
Establish in vivo Models of Infection
At present, in vivo models of C. daubneyi infection (e.g., using cattle or sheep) are lacking. Establishment of such models, using defined doses of metacercariae, would allow basic parasitological observations to be made, such as the timing of fluke development/patency (currently unknown) or the quantification of egg output. Moreover, in vivo models of C. daubneyi infection would allow correlates of fluke burden with egg output to be determined which would validate copromicroscopic techniques for detection of chronic paramphistomosis. The timing and extent of host pathology associated with acute rumen fluke infection could also be more accurately assessed and how this correlates with the burden of immature larvae in the duodenum. Characterization of the host immune response to rumen fluke infection, and how this changes as infection progresses to chronicity, would be of particular value and would facilitate vaccine trials and the development of immune-based diagnostic tools. Since a rumen fluke vaccine is likely to be some way off, repurposing of existing anthelmintics may be an attractive alternative and determining their efficacy in vivo would expedite this process.
Develop in vitro Models of Acute Infection
We recently developed a new technique for excystment of C. daubneyi metacercariae (32). This consistently gave >80% excystment and has allowed us to study the infective NEJ stage in vitro. This development could permit detailed investigations into C. daubneyi infectivity, if suitable in vitro infection models can be developed. These could be based upon gut loop assays which have been used to probe mechanisms of secretion in Fasciola gigantica NEJs (33) and to determine the role of cathepsins B and L in gut penetration by F. hepatica NEJs (34).
Identify Key Virulence and Invasion Factors Secreted by C. daubneyi
We have recently shown (using transcriptome and proteome analysis) that, following excystment, F. hepatica NEJs rapidly undergo significant developmental changes, and secrete a specific battery of virulence-associated proteins in order to establish infection in the mammalian host (30). At present, only the secretome of adult rumen fluke has been characterized (32). Further work to investigate the tissue-invasion strategy, and virulence factors, used by C. daubneyi NEJs to establish new infections in the host duodenal submucosa are thus required. This may allow the development of vaccines or other treatments aimed at limiting the damaging pathology that is the hallmark of acute paramphistomosis.
Characterize the Host Immune Response to C. daubneyi Infection
Helminths have the capacity to suppress or regulate both innate and adaptive immune responses to promote their survival within the host. Whilst the immunological parameters of infection are well-defined for nematodes and liver fluke (35–37) we know little about this during C. daubneyi infections. However, it is evident that, unlike liver fluke, there is considerable host immunity to re-infection with rumen fluke if sheep are re-challenged following priming with the intestinal phase of the primary infection (23). Studies, using experimentally infected sheep/cattle, would allow the pathological and immunological responses to both primary and secondary C. daubneyi infections to be investigated in order to define immune signatures of protection. Furthermore, this would allow investigation of the immune outcomes of co-infection of rumen fluke with F. hepatica and/or gastrointestinal nematodes.
Conclusions
With the possibility of clinical outbreaks of paramphistomosis increasing in the future, it is important that we begin to investigate the basic biology of C. daubneyi now, with emphasis on host pathology and immune evasion. Uniquely, studies from the 1960's indicate that protective immunity occurs for paramphistomosis and that successful vaccination could be possible. However, these observations require detailed follow-up investigation using the raft of immunological reagents, biological resources and molecular tools available today. Although some way off, a vaccine could prolong the useful life of oxyclozanide which is currently the only drug recommended, although not licensed, for rumen fluke infection. Pursuit of the basic research areas outlined here would be a starting point for such translational developments.
Author Contributions
MR, TM, and PS conceived the research priorities described. EA, MR, NO, TM, and PS wrote the manuscript. NO contributed figures. All authors contributed to the article and approved the submitted version.
Funding
MR was supported by an Industrial Partnership Award from the Biotechnology and Biological Sciences Research Council (BB/N017757/1) with additional financial support from Agrisearch and AHDB Beef & Lamb. NO was supported by a postgraduate studentship from the Department for the Economy (DfE) Northern Ireland. PS and TM are supported by the Scottish Government Rural and Environment Science and Analytical Services Division (RESAS) Strategic Research Programme, 2016–2021.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The handling Editor declared a past co-authorship with one of the authors PS.
References
1. Huson KM, Oliver NAM, Robinson MW. Paramphistomosis of ruminants: an emerging parasitic disease in Europe. Trends Parasitol. (2017) 33:836–44. doi: 10.1016/j.pt.2017.07.002
2. Gordon DK, Roberts LCP, Lean N, Zadoks RN, Sargison ND, Skuce PJ. Identification of the rumen fluke, Calicophoron daubneyi, in GB livestock: possible implications for liver fluke diagnosis. Vet Parasitol. (2013) 195:65–71. doi: 10.1016/j.vetpar.2013.01.014
3. O'Toole A, Browne JA, Hogan S, Bassiere T, DeWaal T, Mulcahy G, et al. Identity of rumen fluke in deer. Parasitol Res. (2014) 113:4097–103. doi: 10.1007/s00436-014-4078-3
4. Martinez-Ibeas AM, Munita MP, Lawlor K, Sekiya M, Mulcahy G, Sayers R. Rumen fluke in Irish sheep: prevalence, risk factors and molecular identification of two paramphistome species. BMC Vet Res. (2016) 12:143. doi: 10.1186/s12917-016-0770-0
5. Ploeger HW, Ankum L, Moll L, van Doorn DCK, Mitchell G, Skuce PJ, et al. Presence and species identity of rumen flukes in cattle and sheep in the Netherlands. Vet Parasitol. (2017) 243:42–6. doi: 10.1016/j.vetpar.2017.06.009
6. Skuce PJ, Morgan ER, van Dijk J, Mitchell M. Animal health aspects of adaptation to climate change: beating the heat and parasites in a warming Europe. Animal. (2013) 7(Suppl.2):333–45. doi: 10.1017/S175173111300075X
7. Jones RA, Williams HW, Dalesman S, Brophy PM. Confirmation of Galba truncatula as an intermediate host snail for Calicophoron daubneyi in Great Britain, with evidence of alternative snail species hosting Fasciola hepatica. Parasit Vectors. (2015) 8:656–4. doi: 10.1186/s13071-015-1271-x
8. O'Shaughnessy J, Garcia-Campos A, McAloon CG, Fagan S, de Waal T, McElroy M, et al. Epidemiological investigation of a severe rumen fluke outbreak on an Irish dairy farm. Parasitology. (2018) 145:948–52. doi: 10.1017/S0031182017002086
9. Devos J, Vassiloglou B, Amenna-Bernard N, Marcotty T. Paramphistomosis in sheep; natural infection of lambs by Calicophoron daubneyi. Rev Med Vet Toulouse. (2013) 164:528–35.
10. Horak IG. Paramphistomiasis of domestic ruminants. Adv Parasitol. (1971) 9:33–72. doi: 10.1016/S0065-308X(08)60159-1
11. Northern Ireland disease surveillance report. October to December 2016. Vet Rec. (2017) 180:112–6. doi: 10.1136/vr.j485
12. Millar M, Colloff A, Scholes S. Disease associated with immature paramphistome infection. Vet Rec. (2012) 171:509–10. doi: 10.1136/vr.e7738
13. Sanabria REF, Romero JR. Review and update of paramphistomosis. Helminthologia. (2008) 45:64. doi: 10.2478/s11687-008-0012-5
14. Fuertes M, Pérez V, Benavides J, González-Lanza MC, Mezo M, González-Warleta M, et al. Pathological changes in cattle naturally infected by Calicophoron daubneyi adult flukes. Vet Parasitol. (2015) 209:188–96. doi: 10.1016/j.vetpar.2015.02.034
15. Mason C, Stevenson H, Cox A, Dick I, Rodger C. Disease associated with immature paramphistome infection in sheep. Vet Rec. (2012) 170:343–4. doi: 10.1136/vr.e2368
16. Kajugu PE, Hanna RE, Edgar HW, Forster FI, Malone FE, Brennan GP, et al. Specificity of a coproantigen ELISA test for fasciolosis: lack of cross-reactivity with Paramphistomum cervi and Taenia hydatigena. Vet Rec. (2012) 171:502. doi: 10.1136/vr.101041
17. Arias MS, Sanchís J, Francisco I, Francisco R, Pineiro P, Cazapal-Monteiro C, et al. The efficacy of four anthelmintics against Calicophoron daubneyi in naturally infected dairy cattle. Vet Parasitol. (2013) 197:126–9. doi: 10.1016/j.vetpar.2013.06.011
18. Rolfe PF, Boray JC. Chemotherapy of paramphistomosis in cattle. Aust Vet J. (1987) 64:328–32. doi: 10.1111/j.1751-0813.1987.tb06060.x
19. Malrait K, Verschave S, Skuce P, Van Loo H, Vercruysse J, Charlier J. Novel insights into the pathogenic importance, diagnosis and treatment of the rumen fluke (Calicophoron daubneyi) in cattle. Vet Parasitol. (2015) 207:134–9. doi: 10.1016/j.vetpar.2014.10.033
20. Paraud C, Gaudin C, Pors I, Chartier C. Efficacy of oxyclozanide against the rumen fluke Calicophoron daubneyi in experimentally infected goats. Vet J. (2009) 180:265–7. doi: 10.1016/j.tvjl.2008.01.002
21. Boray JC. The anthelmintic efficiency of niclosamide and menichlopholan in the treatment of intestinal paramphistomosis in sheep. Aust Vet J. (1969) 45:133–5. doi: 10.1111/j.1751-0813.1969.tb01905.x
22. Horak IG. Studies on paramphistomiasis v. the immunisation of sheep, goats and cattle preliminary report. J South African Vet Assoc. (1965) 36:361–3.
23. Horak IG. Host-parasite relationships of Paramphistomum microbothrium Fischoeder, 1901, in experimentally infested ruminants, with particular reference to sheep. Onderstepoort J Vet Res. (1967) 34:451–540.
24. Ferreras MC, González-Lanza C, Pérez V, Fuertes M, Benavides J, Mezo M, et al. Calicophoron daubneyi (Paramphistomidae) in slaughtered cattle in Castilla y León (Spain). Vet Parasitol. (2014) 199:268–71. doi: 10.1016/j.vetpar.2013.10.019
25. Spithill TW. Development of Vaccines Against Fasciola hepatica. Fasciolosis; Oxford: CABI (1999).
26. Molina Hernandez V, Mulcahy G, Perez J, Martinez-Moreno A, Donnelly S, O'Neill SM, et al. Fasciola hepatica vaccine: we may not be there yet but we're on the right road. Vet Parasitol. (2015) 208:101–11. doi: 10.1016/j.vetpar.2015.01.004
27. Cwiklinski K, la Torre-Escudero de E, Trelis M, Bernal D, Dufresne PJ, Brennan GP, et al. The extracellular vesicles of the helminth pathogen, Fasciola hepatica: biogenesis pathways and cargo molecules involved in parasite pathogenesis. Mol Cell Proteomics. (2015) 14:3258–73. doi: 10.1074/mcp.M115.053934
28. Cwiklinski K, O'Neill SM, Donnelly S, Dalton JP. A prospective view of animal and human Fasciolosis. Parasite Immunol. (2016) 38:558–68. doi: 10.1111/pim.12343
29. Ruiz-Campillo MT, Molina Hernandez V, Escamilla A, Stevenson M, Perez J, Martinez-Moreno A, et al. Immune signatures of pathogenesis in the peritoneal compartment during early infection of sheep with Fasciola hepatica. Sci Rep. (2017) 7:2782–14. doi: 10.1038/s41598-017-03094-0
30. Cwiklinski K, Jewhurst H, McVeigh P, Barbour T, Maule AG, Tort J, et al. Infection by the helminth parasite Fasciola hepatica requires rapid regulation of metabolic, virulence, and invasive factors to adjust to its mammalian host. Mol Cell Proteomics. (2018) 17:792–809. doi: 10.1074/mcp.RA117.000445
31. Ravidà A, Cwiklinski K, Aldridge AM, Clarke P, Thompson R, Gerlach JQ, et al. Fasciola hepatica surface tegument: glycoproteins at the interface of parasite and host. Mol Cell Proteomics. (2016) 15:3139–53. doi: 10.1074/mcp.M116.059774
32. Huson KM, Wild C, Fenn C, Robinson MW. Optimized conditions for the in vitro excystment of Calicophoron daubneyi metacercariae. Parasitology. (2018) 145:1015–9. doi: 10.1017/S0031182017002220
33. Hanna REB, Moffett D, Robinson MW, Jura WGZO, Brennan GP, Fairweather I. Fasciola gigantica: comparison of the tegumental ultrastructure in newly excysted metacercariae and in vitro penetrated juvenile flukes indicates intracellular sources of molecules with vaccinal and immunomodulatory potential. Vet Parasitol. (2019) 265:38–47. doi: 10.1016/j.vetpar.2018.11.019
34. McGonigle L, Mousley A, Marks NJ, Brennan GP, Dalton JP, Spithill TW, et al. The silencing of cysteine proteases in Fasciola hepatica newly excysted juveniles using RNA interference reduces gut penetration. Int J Parasitol. (2008) 38:149–55. doi: 10.1016/j.ijpara.2007.10.007
35. Dalton JP, Robinson MW, Mulcahy G, O'Neill SM, Donnelly S. Immunomodulatory molecules of Fasciola hepatica: candidates for both vaccine and immunotherapeutic development. Vet Parasitol. (2013) 195:272–85. doi: 10.1016/j.vetpar.2013.04.008
36. McNeilly TN, Devaney E, Matthews JB. Teladorsagia circumcincta in the sheep abomasum: defining the role of dendritic cells in T cell regulation and protective immunity. Parasite Immunol. (2009) 31:347–56. doi: 10.1111/j.1365-3024.2009.01110.x
Keywords: Calicophoron daubneyi, rumen fluke, paramphistomosis, host-parasite interactions, pathogenicity, immunomodulation
Citation: Atcheson E, Skuce PJ, Oliver NAM, McNeilly TN and Robinson MW (2020) Calicophoron daubneyi—The Path Toward Understanding Its Pathogenicity and Host Interactions. Front. Vet. Sci. 7:606. doi: 10.3389/fvets.2020.00606
Received: 12 June 2020; Accepted: 28 July 2020;
Published: 04 September 2020.
Edited by:
Theo De Waal, University College Dublin, IrelandReviewed by:
Laura Rinaldi, University of Naples Federico II, ItalyChristophe Chartier, INRA Biologie, Épidémiologie et Analyse de Risque en santé animale (BIOEPAR), France
Copyright © 2020 Atcheson, Skuce, Oliver, McNeilly and Robinson. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Mark W. Robinson, mark.robinson@qub.ac.uk